EMEA-002303-PIP01-17-M04 - paediatric investigation plan

Etripamil

Key facts

• Active Substance:
  Etripamil
• Therapeutic area:
  Cardiac disorders
• Decision number:
  P/0011/2024
• PIP number:
  EMEA-002303-PIP01-17-M04
• Pharmaceutical form(s):
  Nasal spray (solution)
• Condition(s) / indication(s):
  Treatment of supraventricular arrhythmia
• Route(s) of administration:
  Intranasal use
• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  31/01/2024

Decision

P/0011/2024 : EMA decision of 31 January 2024 on the acceptance of a modification of an agreed paediatric investigation plan for etripamil, (EMEA- 002303-PIP01-17-M04)

AdoptedReference Number: EMA/25515/2024